Press Release Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts Acrivon Therapeutics, Inc · Aug 12
Press Release ArriVent BioPharma Reports Second Quarter 2026 Financial Results ArriVent BioPharma, Inc. · Aug 12
Press Release Lumexa Imaging Announces Second Quarter 2026 Results Lumexa Imaging Holdings, Inc. · Aug 12
Press Release SKYX Reports 14% Growth and Record Sales of $25.3 Million in Q-2 2026 Compared to $22.1 Million in Q-1 2026 and 10 Consecutive Quarters of Growth YoY and as It Continues to Grow Its Market Penetration SKYX Platforms Corp. · Aug 12
Press Release SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates SeaStar Medical · Aug 12
Press Release Byrna Appoints Retired U.S. Army Brigadier General Rose Lopez Keravuori to Board of Directors Byrna Technologies, Inc. · Aug 12
Press Release Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update Allogene Therapeutics, Inc. · Aug 12
Press Release Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants Outlook Therapeutics, Inc. · Aug 12
Press Release Resideo Announces Record Second Quarter 2026 Financial Results; Initiates Standalone 2026 Outlook Resideo Technologies, Inc. · Aug 12